AZD6738
A Phase Ib Study of AZD6738 for Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Progressing on Front-Line Therapy
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 52 patients (estimated)
- Sponsors
- Massachusetts General Hospital
- Collaborators
- AstraZeneca
- Tags
- Kinase Inhibitor
- Trial Type
- Treatment
- Last Update
- 1 week ago
- SparkCures ID
- 1560
- NCT Identifier
- NCT03770429
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.